Hipra Scientific S.L.

Address
Avinguda Selva 135

Sponsor Overview

assignment
4
sponsored trials
science
5
molecules
location_city
15
research centres
public
1
country
person_search
15
investigators

Specializations

COVID-19 Booster Vaccination

Hipra Scientific S.L. focuses on SARS-CoV-2 vaccination strategies in adults and adolescents, with research centred on heterologous booster use and adapted recombinant protein vaccine candidates for COVID-19.

  • Booster immunisation in previously vaccinated populations
  • Safety and tolerability evaluation
  • Immunogenicity against emerging variants

The sponsor’s clinical work includes adults with prior mRNA vaccine exposure and adolescents receiving booster protection after primary vaccination.

SARS-CoV-2 Variant Response

Research activity also addresses immune responses to Omicron lineages, including variant-adapted vaccine approaches aimed at maintaining protection against circulating SARS-CoV-2 strains.

  • Omicron XBB.1.16 immune response
  • Omicron BA.1 neutralisation
  • LP.8.1 variant coverage

These studies examine pseudovirus neutralisation outcomes and variant-specific antibody responses in vaccinated populations.

Adolescent and Young Adult Vaccination

The sponsor investigates COVID-19 booster vaccination in younger age groups, including adolescents and young adults, with emphasis on extending protection after initial Comirnaty vaccination.

  • Adolescent booster immunisation
  • Post-vaccination immune response
  • Age-group comparison

Clinical interest extends to comparing immune responses across different adolescent and young adult cohorts.

Influenza and COVID-19 Co-administration

Hipra Scientific S.L. also studies the combined use of COVID-19 vaccination with seasonal influenza immunisation in older adults, reflecting interest in respiratory disease prevention across overlapping vaccination programmes.

  • Coadministration with inactivated influenza vaccine
  • Older adult vaccination
  • Combined respiratory protection

This area links SARS-CoV-2 prevention with influenza vaccination in adults over 65 years of age.

Sponsored Trials

Data & Insights

science
Molecule Portfolio
Compounds under investigation
1
Exclusive Molecules
out of 5 total (20% not shared with other sponsors)

This sponsor works with 5 molecules, of which 1 is not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
27%
Return partnership rate
4 of 15 sites collaborated multiple times

This sponsor has worked with 15 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Virus Diseases4 trials
    182 other sponsors
  • 2.
    Respiratory Tract Diseases1 trial
    277 other sponsors

Partnered Research Centres

15 centres
location_city
assignment3
CAP Peralada
Address
C/ Tolo. 3 - 5, 17491 Peralada
Learn morearrow_forward
location_city
assignment27
Eap Osona Sud Alt Congost S.L.P.
Address
Placa Del Pla Del Mestre 7, 08540 Centelles
Learn morearrow_forward
location_city
assignment186
Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer
Address
Villarroel 170, Department of Psychiatry and Psychology, Neuroscience Institute, 08036 Barcelona
Learn morearrow_forward
location_city
assignment944
Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz
Address
Paseo De La Castellana 261, 28046 Madrid
Learn morearrow_forward
location_city
assignment114
Hospital Clinico Universitario De Valladolid
Address
Avenida Ramon Y Cajal 3, 47003 Valladolid
Learn morearrow_forward
location_city
assignment97
Hospital Hm Nou Delfos
Address
Avinguda De Vallcarca 151, 08023 Barcelona
Learn morearrow_forward
Page 1 of 3

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Hipra Scientific S.L..

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.